Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
12 | 25225676 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2018 | 2018 | |||||||||
|
12 | 25225657 | missense variant | C/T | snv | 1.2E-05 | 7.0E-06 |
|
0.010 | 1.000 | 1 | 2014 | 2014 | |||||||||
|
12 | 25227262 | missense variant | T/C | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
12 | 25227262 | missense variant | T/C | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Neoplasms | 0.100 | 0.970 | 67 | 1999 | 2020 | |||||||
|
0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Neoplasms; Respiratory Tract Diseases | 0.790 | 1.000 | 26 | 2002 | 2019 | |||||||
|
0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Neoplasms; Respiratory Tract Diseases | 0.800 | 0.933 | 15 | 2010 | 2019 | |||||||
|
0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.100 | 0.857 | 14 | 2003 | 2016 | |||||||
|
0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Neoplasms | 0.100 | 1.000 | 13 | 2008 | 2019 | |||||||
|
0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Digestive System Diseases; Neoplasms | 0.800 | 0.923 | 13 | 1999 | 2020 | |||||||
|
0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Digestive System Diseases; Neoplasms | 0.700 | 1.000 | 12 | 2005 | 2014 | |||||||
|
0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Neoplasms; Respiratory Tract Diseases | 0.100 | 0.909 | 11 | 2010 | 2019 | |||||||
|
0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Neoplasms; Respiratory Tract Diseases | 0.100 | 0.909 | 11 | 2010 | 2019 | |||||||
|
0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Neoplasms | 0.100 | 1.000 | 11 | 2009 | 2019 | |||||||
|
0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Respiratory Tract Diseases | 0.100 | 1.000 | 10 | 2010 | 2018 | |||||||
|
0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.820 | 1.000 | 10 | 2005 | 2019 | |||||||
|
0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Neoplasms | 0.100 | 1.000 | 10 | 2009 | 2019 | |||||||
|
0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.710 | 1.000 | 9 | 2005 | 2011 | |||||||
|
0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Neoplasms; Respiratory Tract Diseases | 0.080 | 0.875 | 8 | 2008 | 2016 | |||||||
|
0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Neoplasms | 0.070 | 1.000 | 7 | 2012 | 2020 | |||||||
|
0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.060 | 1.000 | 6 | 2009 | 2016 | |||||||
|
0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
0.060 | 1.000 | 6 | 2012 | 2019 | ||||||||
|
0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Neoplasms | 0.710 | 1.000 | 6 | 1987 | 2014 | |||||||
|
0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Digestive System Diseases; Neoplasms; Endocrine System Diseases | 0.050 | 1.000 | 5 | 2003 | 2019 | |||||||
|
0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Pathological Conditions, Signs and Symptoms | 0.050 | 0.800 | 5 | 2011 | 2017 |